share this article!

getty
Every day, Q.ai brings you a list of the hottest stocks on the market – or, at the very least, the stocks that are at the top of our trending list. We’ve added a few new names to the list this week, ranging from chemical manufacturers to API providers to (potentially) listeria-infected poultry. Let’s take a look behind the curtain to see what else is lurking in today’s trending stocks.
To gain the most up-to-date information on stocks and ETFs, Q.ai runs daily factor models. Our deep-learning algorithms use Artificial Intelligence (AI) technology to deliver a comprehensive, intelligence-based analysis of a company, so you don’t have to.
To join an exclusive AI investing community and receive premium investing ideas before markets open, sign up for the free Forbes AI Investor newsletter here.
DuPont de Nemours & Company, Inc. (DD)
On a volume of 2 million trades, DuPont de Nemours, Inc rose 0.24 percent to $78.79 per share on Friday. The stock is trading between its 10- and 22-day price averages, with a year-to-date gain of roughly 10.8%. DuPont is currently trading at 19.9 times projected earnings.
DuPont is a chemical and manufacturing firm that does just about everything. The corporation has its fingers in many pies, from making protective equipment to generating chemicals to advancing new “smart” apparel – and a few controversies, which saw the company’s value fall even before the epidemic arrived.
ADDITIONAL INFORMATION FOR YOU
Despite its recent unsuccessful year, the board of directors recently announced that DuPont would pay $0.30 per share on September 15, bringing the company’s quarterly dividend in line with industry standards.

5-year performance of DuPont de Nemour
Forbes Investor in Artificial Intelligence
DuPont’s sales in the most recent fiscal year was $20.4 billion, down from $22.6 billion three years ago. Operating income has also declined from $3.87 billion to just under $1.7 billion over the last three years, while per-share earnings have dropped from $4.96 to $4.02. However, ROE has increased from 0.4 percent to over 7.1 percent over the same time span.
DuPont’s forward 12-month revenue is predicted to expand by roughly 1.5 percent at this time. This company receives a B in Low Volatility Momentum, Cs in Growth and Quality Value, and a F in Technicals, according to our AI.
On the back of 600,600 trades, Agora, Inc (API) dropped 5% to $39.40 per share on Friday. The stock is down 0.4 percent year to date and from its 22-day price average.
Agora, a Chinese cloud software developer, is a real-time engagement API provider that made its public debut in June 2020. In its first public offering, the stock sold 17.5 million shares for $350 million, bringing the company’s total worth to $880 million by the end of the first trading day.
Customers were looking for the technological tools they required to work from home productively as the stock’s worth skyrocketed. When Zoom is the primary mode of communication, Agora’s software enables communication networks and helps developers to insert voice and video tools into apps – a fundamental but critical feature.

CNBC reports on Agora’s success following its IPO in June 2020.
Agora’s experience paid dividends in the previous fiscal year, as revenue increased 3.5 percent to $133.6 million, up 216 percent from $43.7 million three years prior. Furthermore, operating income increased by nearly 292 percent to $5.2 million in the last fiscal year, compared to $0.26 million three years ago, and per-share earnings nearly doubled from $1.57 to $3.02.
In the coming year, Agora is predicted to enjoy a staggering revenue growth of roughly 12.5 percent. Our AI, on the other hand, gives this stock a D in Technicals and a C in Growth, Low Volatility Momentum, and Quality Value at this moment.
Tyson Foods, Inc (TSN): On Friday, Tyson Foods, Inc lost 0.3 percent of its value, but it still ended the year with a 14.2 percent gain. On the day, almost 1 million shares were traded, bringing the stock’s forward earnings ratio down to 13.2x.
Tyson Foods is the large, red brand on the frozen chicken packs you bring home from the store every time you go grocery shopping. Tyson is in the news this week for all the wrong reasons, as the huge meatpacker is (voluntarily) recalling over 8.5 million pounds of fully cooked chicken products due to probable listeria contamination.
The CDC also issued a food safety notice for the goods, which were distributed to Walmart, Wegmans, and Publix stores, as well as restaurants, hospitals, schools, and nursing homes.

Tyson’s five-year record
Forbes Investor in Artificial Intelligence
While the epidemic wreaked havoc on the meatpacking business, it spared the likes of Tyson. The company’s revenue increased 0.1 percent to $43 billion in the last fiscal year, up from $40 billion three years ago, while per-share earnings increased 5.6 percent to $3.7 billion, up from $3.2 billion. Meanwhile, EPS increased 3% year over year to $5.64 per share, a considerable decrease from the $8.04 per share earned three years ago. In addition, return on equity dropped from 25.4 percent to 14%.
In the following twelve months, Tyson Foods is predicted to raise its revenue by 2.6 percent. Our AI gives this company a B in Low Volatility Momentum, Cs in Growth and Quality Value, and a D in Technicals, indicating that it is a fair investment.
Spero Therapeutics, Inc (SPRO) fell about 3.7 percent to $15.79 on Friday, completing the day with nearly 300,000 trades and a year-to-date loss of 18.6 percent. Nonetheless, the company is trading roughly a dollar higher than its 10- and 22-day price averages.
Spero Therapeutics is a clinical-stage biopharmaceutical business focused on the development and promotion of medicines for multidrug-resistant illnesses and infections. The business is on the rise after signing an agreement with Pfizer last week to develop, produce, and market Spero’s IV-administered medication candidate to treat serious Gram-negative infections in hospital settings outside of Asia and the United States.
Spero will get a portion of any prospective milestone payments, which may be worth up to $80 million, as well as royalties on net sales in the relevant areas. Pfizer made a $40 million equity investment in Spero as part of the Pfizer Breakthrough Growth Initiative, a program that funds creative solutions to patient needs.

Spero Therapeutics has a 5-year track record of success.
Forbes Investor in Artificial Intelligence
Spero Therapeutics’ revenue increased by 276.4 percent in the last three fiscal years, from over $4 million to over $9.3 million. Operating income increased by 76.8% in the same time, from $42.8 million to $79.1 million, while per-share earnings increased by 15% to $3.52, compared to $2.60 EPS three years prior. Spero’s return on equity than doubled, going from 41.5 percent to 75.8 percent.
Our AI currently gives Spero Therapeutics a D in Technicals, a C in Low Volatility Momentum, and a F in Quality Value. The company’s Growth was not valued by our deep-learning algorithms.
Albertsons Companies, Inc (ACI) rose 0.25 percent to $19.96 per share on Friday, with 418,700 trades on the day and a 13.5 percent YTD gain. Albertsons Companies now has a future 12-month P/E ratio of 11.2x.
Albertsons Companies is a grocery store company based in the United States that is the second-largest in North America (after Kroger). In addition to Washington, D.C., the corporation operates under several brands in more than 30 states.
Albertsons became a trending topic two weeks ago when it announced a collaboration with DoorDash to provide on-demand grocery delivery from roughly 2,000 of its 2,260 locations. Expansion of delivery hours, prepared meals and meal packages, speciality items, and a new bespoke loyalty program are also available.

Since its IPO in June 2020, Albertsons has performed well.
Forbes Investor in Artificial Intelligence
Albertsons’ revenue increased by 15.1 percent to $69.7 billion in the last three fiscal years, up from $60.5 billion three years ago. Operating income increased 162 percent to $2.35 billion from $895 million three years earlier, while per-share earnings increased 551 percent to $1.47 from just 23 cents. In addition, return on equity than doubled during this time, rising from 9.2 percent to 32.7 percent.
Albertsons currently has a B in Technicals and Quality Value, a C in Low Volatility Momentum, and a big, fat F in Growth, according to our AI.
Did you enjoy what you read? To receive monthly AI-driven investing ideas, sign up for our free Forbes AI Investor Newsletter. Subscribers can join an exclusive Slack channel for a short time to obtain these ideas before the markets open./nRead More

share this article!